Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delayed type hypersensitivity to benzoyl peroxide.

Christina Shwereb1, Eve J Lowenstein

  • 1SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

Journal of Drugs in Dermatology : JDD
|April 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pentoxifylline and long-term risk of keloid formation: A real-world 10-year outcomes study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same author

Asymptomatic pitted lesions of bilateral hands and feet.

JAAD case reports·2024
Same author

Jewish women in dermatology.

Clinics in dermatology·2024
Same author

Scapegoats and Silence.

Skinmed·2024
Same author

Tribute to the Masters Part Three: 1840-1900.

Skinmed·2024
Same author

Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise.

JAMA dermatology·2023
Same journal

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

Journal of drugs in dermatology : JDD·2026
Same journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation.

Journal of drugs in dermatology : JDD·2026
Same journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026
Same journal

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans.

Journal of drugs in dermatology : JDD·2026
Same journal

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review.

Journal of drugs in dermatology : JDD·2026
See all related articles

Benzoyl peroxide (BP) is a common acne treatment. This report details a rare, incipient edematous reaction to BP, highlighting under-recognized hypersensitivity presentations.

Area of Science:

  • Dermatology
  • Allergology
  • Pharmacology

Background:

  • Benzoyl peroxide (BP) has been a mainstay topical acne vulgaris treatment for over 35 years.
  • BP is recognized as a potent irritant and weak allergen, with tolerance often developing upon repeated use.
  • While rare, allergic contact dermatitis (delayed-type hypersensitivity) to BP has been documented.

Observation:

  • This report presents a case of an incipient edematous reaction to topical BP in an acne patient.
  • The observed reaction represents an under-recognized clinical presentation of BP hypersensitivity.

Findings:

  • The case highlights a specific type of hypersensitivity reaction to benzoyl peroxide.
  • This reaction, characterized by edema, is less commonly reported than typical allergic contact dermatitis.

Related Experiment Videos

Implications:

  • Clinicians should consider BP-induced hypersensitivity, including edematous reactions, in patients presenting with adverse effects during acne treatment.
  • Further recognition of this presentation may improve diagnosis and management of benzoyl peroxide-related adverse events.